The effect of exercise and motor interventions on physical activity and motor outcomes during and after medical intervention for children and adolescents with acute lymphoblastic leukemia: A systematic review.

Szczegóły
Abstrakt

Tytuł:: The effect of exercise and motor interventions on physical activity and motor outcomes during and after medical intervention for children and adolescents with acute lymphoblastic leukemia: A systematic review.
Autorzy:: Coombs A; Children's Hospital Los Angeles, Division of Pediatric Rehabilitation Medicine, 4650 Sunset Blvd., Los Angeles, CA, 90027, United States; University of Southern California, Division of Biokinesiology and Physical Therapy, Herman Ostrow School of Dentistry, Los Angeles, CA, United States. Electronic address: .
Schilperoort H; University of Southern California, Norris Medical Library, Los Angeles, CA, United States.
Sargent B; University of Southern California, Division of Biokinesiology and Physical Therapy, Herman Ostrow School of Dentistry, Los Angeles, CA, United States.
Źródło:: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2020 Aug; Vol. 152, pp. 103004. Date of Electronic Publication: 2020 May 27.
Typ publikacji:: Journal Article; Systematic Review
Język:: English
Imprint Name(s):: Publication: <2005->: Amsterdam : Elsevier Scientific Publishers
Original Publication: Boca Raton, Fla. : CRC Press, 1983-
MeSH Terms:: Exercise*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Adolescent ; Bone Density ; Child ; Exercise Tolerance ; Fatigue ; Humans
References:: Pediatr Blood Cancer. 2017 Nov;64(11):. (PMID: 28423225)
J Adolesc Young Adult Oncol. 2016 Jun;5(2):91-105. (PMID: 26871647)
Nutrients. 2019 Nov 02;11(11):. (PMID: 31684118)
Cancer Causes Control. 2015 Nov;26(11):1627-42. (PMID: 26376890)
Pediatr Blood Cancer. 2009 Sep;53(3):438-43. (PMID: 19415742)
Psychooncology. 2009 Apr;18(4):440-8. (PMID: 19242926)
J Oncol Pract. 2016 Sep;12(9):765-7. (PMID: 27531379)
Arch Dis Child. 2020 Nov;105(11):1035-1040. (PMID: 32198161)
J Sports Sci Med. 2012 Sep 01;11(3):387-92. (PMID: 24149344)
Phys Ther. 2019 Jan 1;99(1):10-13. (PMID: 30329114)
J Clin Oncol. 2012 May 10;30(14):1663-9. (PMID: 22412151)
PLoS One. 2017 Oct 24;12(10):e0186787. (PMID: 29065156)
PLoS Med. 2009 Jul 21;6(7):e1000097. (PMID: 19621072)
Pediatr Blood Cancer. 2014 May;61(5):894-900. (PMID: 24436138)
Int J Sports Med. 2020 Mar;41(3):141-153. (PMID: 31935777)
Pediatr Blood Cancer. 2017 Jan;64(1):13-17. (PMID: 27468131)
J Clin Med. 2020 Feb 19;9(2):. (PMID: 32092881)
Pediatr Rehabil. 2006 Jul-Sep;9(3):267-74. (PMID: 17050404)
Crit Rev Oncol Hematol. 2019 Oct;142:94-118. (PMID: 31394434)
Pediatr Blood Cancer. 2009 Jul;53(1):64-71. (PMID: 19283791)
Pediatr Blood Cancer. 2004 Feb;42(2):127-33. (PMID: 14752875)
Med Sci Sports Exerc. 2007 Jan;39(1):13-21. (PMID: 17218878)
J Pediatr Hematol Oncol. 2009 Apr;31(4):259-66. (PMID: 19346877)
Cochrane Database Syst Rev. 2016 Mar 31;3:CD008796. (PMID: 27030386)
Pediatr Blood Cancer. 2007 Dec;49(7):975-81. (PMID: 17091482)
Crit Rev Oncol Hematol. 2018 Jan;121:90-100. (PMID: 29198853)
Pediatr Blood Cancer. 2018 May;65(5):e26924. (PMID: 29314654)
Health Psychol Rev. 2013;7(1):92-110. (PMID: 25484907)
Expert Rev Hematol. 2011 Apr;4(2):185-97. (PMID: 21495928)
Cancer. 2009 May 1;115(9):1984-94. (PMID: 19224548)
Clin Rehabil. 2014 Dec;28(12):1159-71. (PMID: 24942478)
Pediatr Blood Cancer. 2013 Nov 6;:. (PMID: 24623535)
JAMA Neurol. 2018 Aug 1;75(8):980-988. (PMID: 29799906)
Support Care Cancer. 2020 Jul;28(7):3171-3178. (PMID: 31707503)
Pediatr Blood Cancer. 2016 Apr;63(4):684-9. (PMID: 26756736)
Syst Rev. 2016 May 10;5:80. (PMID: 27160280)
BMJ. 2016 Oct 12;355:i4919. (PMID: 27733354)
J Pediatr Oncol Nurs. 2016 Nov/Dec;33(6):422-431. (PMID: 27385664)
Cancer Treat Rev. 2018 Nov;70:154-167. (PMID: 30218787)
Patient Educ Couns. 2016 Jul;99(7):1099-1105. (PMID: 26879805)
Pediatr Blood Cancer. 2016 Sep;63(9):1586-93. (PMID: 27186955)
Pediatr Blood Cancer. 2019 May;66(5):e27596. (PMID: 30609245)
Turk J Pediatr. 2017;59(6):678-683. (PMID: 30035400)
Crit Rev Oncol Hematol. 2017 Oct;118:27-41. (PMID: 28917267)
Psychooncology. 2010 Sep;19(9):997-1003. (PMID: 19918964)
Pediatr Blood Cancer. 2018 Apr;65(4):. (PMID: 29286560)
Med Pediatr Oncol. 2003 Apr;40(4):230-2. (PMID: 12555250)
Scand J Med Sci Sports. 2020 Jan;30(1):126-134. (PMID: 31482597)
Rehabil Nurs. 2013 Jan-Feb;38(1):48-59. (PMID: 23365005)
Crit Rev Oncol Hematol. 2019 Apr;136:79-85. (PMID: 30878132)
Semin Oncol Nurs. 2020 Feb;36(1):150984. (PMID: 31983485)
Pediatr Hematol Oncol. 2015;32(8):585-612. (PMID: 26558954)
Pediatr Int. 2017 Mar;59(3):293-302. (PMID: 27543960)
Crit Rev Oncol Hematol. 2016 Dec;108:128-136. (PMID: 27931830)
Cancer Nurs. 2011 Jan-Feb;34(1):3-12. (PMID: 20706112)
Phys Ther. 2005 Aug;85(8):782-90. (PMID: 16048425)
Eur J Paediatr Neurol. 2019 Mar;23(2):304-316. (PMID: 30611625)
Int J Child Health Nutr. 2012;1(1):44-58. (PMID: 26973721)
Arch Phys Med Rehabil. 2016 Nov;97(11):2006-2015. (PMID: 27237580)
J Adolesc Young Adult Oncol. 2015 Dec;4(4):184-91. (PMID: 26697268)
Grant Information:: K12 HD055929 United States HD NICHD NIH HHS
Contributed Indexing:: Keywords: ALL; Exercise; Late effects; Leukemia; Motor interventions; Pediatric oncology; Physical activity
Entry Date(s):: Date Created: 20200625 Date Completed: 20200715 Latest Revision: 20210813
Update Code:: 20240105
PubMed Central ID:: PMC8359930
DOI:: 10.1016/j.critrevonc.2020.103004
PMID:: 32580035
: Czasopismo naukowe

Full Text Finder

Background: Children with acute lymphoblastic leukemia (ALL) experience detrimental effects on motor function during and after chemotherapy. The objective of this systematic review was to evaluate the effect of exercise and motor interventions on physical activity and motor outcomes of children with ALL during and after chemotherapy.
Methods: Ten databases were searched. Nineteen studies were included: 11 randomized clinical trials (RCT), 2 controlled clinical trials (CCT), and 6 cohort studies.
Results: Participants included 508 children with ALL. Between-group results from RCTs and CCTs supported that exercise and motor intervention improved: fatigue during acute chemotherapy; physical activity, range of motion (ROM), strength, bone mineral density, aerobic capacity, and fatigue during maintenance chemotherapy; functional mobility, ROM, strength, and aerobic capacity during post-treatment survivorship; and participation, physical activity, ROM, strength, and coordination during multiple-phase interventions.
Conclusion: Low quality evidence supports the efficacy of motor and exercise interventions for children and adolescents with ALL.
Competing Interests: Declaration of Competing Interest None to declare.
(Copyright © 2020 Elsevier B.V. All rights reserved.)

Informacja